H. Levenga

发表

Immunogenicity of dendritic cells pulsed with MAGE3, Survivin and B-cell maturation antigen mRNA for vaccination of multiple myeloma patients

R. Raymakers, F. Preijers, T. Witte, 2013, Cancer Immunology, Immunotherapy.

Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype.

M. Kersten, Stefan Boehringer, A. van den Berg, 2021, Blood advances.

Dynamics in chimerism of T cells and dendritic cells in relapsed CML patients and the influence on the induction of alloreactivity following donor lymphocyte infusion

J. Jansen, R. Raymakers, T. Witte, 2007, Bone Marrow Transplantation.

RANKL inhibition for giant cell lesions of the jaw: A retrospective cohort analysis.

M. Witjes, H. Gelderblom, A. Westermann, 2022, European journal of cancer.

A Polymorphism in the Splice Donor Site of ZNF419 Results in the Novel Renal Cell Carcinoma-Associated Minor Histocompatibility Antigen ZAPHIR

M. Kester, M. Griffioen, P. D. De Mulder, 2011, PloS one.

Improving the identification of frail elderly newly diagnosed multiple myeloma patients

K. Nasserinejad, P. Sonneveld, M. Levin, 2021, Leukemia.

Fatal hemorrhagic pneumonia caused by infection due to Kytococcus sedentarius—a pathogen or passenger?

P. Verweij, B. D. Pauw, N. Blijlevens, 2004, Annals of Hematology.

Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial.

K. Nasserinejad, A. Kater, D. Issa, 2022, The Lancet. Haematology.

Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma.

R. Raymakers, T. D. de Witte, H. Dolstra, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic stem cell transplantation: exploration of new indications and strategies to exploit graft-versus-tumor immunity for cancer treatment

H. Levenga, 2010 .

Multiple myeloma patients receiving pre-emptive donor lymphocyte infusion after partial T-cell-depleted allogeneic stem cell transplantation show a long progression-free survival

R. Raymakers, H. Dolstra, A. Schattenberg, 2007, Bone Marrow Transplantation.

Bortezomib and donor lymphocyte infusion in multiple myeloma relapsed after allo-SCT does not result in durable remissions

R. Raymakers, L. Vulpen, M. Minnema, 2011, Bone Marrow Transplantation.

Acquired haemophilia A in a patient with breast cancer and lung carcinoma: a case report and literature review.

J. Eikenboom, W. M. van der Deure, H. Levenga, 2019, The Netherlands journal of medicine.

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit CLL patients.

K. Nasserinejad, A. Langerak, A. Kater, 2023, Blood.